Lead sponsor
Arrowhead Pharmaceuticals
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
318
Total enrollment
7
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
2
Trials by status
Recruiting
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusBMI 30-50Ph 1/2Recruiting180
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusBMI 30-50Ph 1/2Recruiting138